Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cardiac complications following cerebrovascular disease

View ORCID ProfileMarco Heinrich Rohner, Catherine Gebhard, View ORCID ProfileAndreas Luft, View ORCID ProfileMartin Hänsel, View ORCID ProfileSusanne Wegener
doi: https://doi.org/10.1101/2023.09.21.23295936
Marco Heinrich Rohner
1Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Heinrich Rohner
Catherine Gebhard
2Department of Cardiology, Inselspital Bern University Hospital, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Luft
1Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland
3Cereneo Center for Neurology and Rehabilitation, Vitznau, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andreas Luft
Martin Hänsel
1Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Hänsel
Susanne Wegener
1Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Susanne Wegener
  • For correspondence: Susanne.Wegener{at}usz.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Accumulating evidence suggest that cardiac complications after stroke are an important yet understudied manifestation of brain-heart interactions. Our aim was to investigate and compare cardiac findings after different cerebrovascular events (acute ischemic stroke, transient ischemic attack, and hemorrhagic stroke).

Methods 7113 patients treated between December 2013 and December 2020 at the University Hospital Zurich for ischemic stroke, transient ischemic attack, and hemorrhagic stroke were screened. 721 patients without evidence of previous cardiac disease or presumed cardioembolic origin of their cerebrovascular disease and with at least one cardiac check-up were included. Clinical reports from the year following disease onset were screened for new cardiac findings, which were categorized as arrhythmia/electrocardiographic (ECG) changes, myocardial alterations, valvular abnormalities, coronary perfusion insufficiency, and hypotensive/hypertensive blood pressure abnormalities. Differences in proportions of findings between groups were analyzed using Pearson’s Chi-Square Test or Fisher’s exact Test.

Results ECG changes were observed in 81.7% of patients with ischemic stroke, 71.4% with transient ischemic attack, and 55.8% with hemorrhagic stroke (p<0.001). Myocardial alterations occurred often in all three groups (60.9% ischemic stroke, 59.2% transient ischemic attack, 44.2% hemorrhage, p=0.1). Hypotensive/hypertensive blood pressure abnormalities were most frequent (48.8%) in hemorrhagic stroke patients (p<0.001).

Conclusions Cardiac complications are frequent in patients with cerebrovascular disease, even without prior cardiac problems or suspected cardiac etiology. While findings were different in the three event types, our data suggest that all patients with acute cerebrovascular events should receive thorough workup searching for cardiac complications.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The project was supported by the Baugarten foundation, the Swiss National Science Foundation (310030_200703 and PP00P3_202663), and the UZH Clinical Research Priority Program (CRPP) Stroke.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the local ethics commission of the canton of Zurich (Kantonale Ethikkommission Zü;rich; KEK-ZH-Nr. 2014-0304).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The data supporting the results of this study can be made available upon reasonable request.

  • Non-standard Abbreviations and Acronyms

    CVD
    Cerebrovascular disease
    IS
    Acute ischemic stroke
    TIA
    Transient ischemic attack
    HS
    Hemorrhagic stroke
    SSR
    Swiss Stroke Registry
    USZ
    University Hospital of Zurich
    TOAST
    Trial of Org 10172 in Acute Stroke Treatment
    CCTA
    Coronary Computed Tomography Angiography
    CMR
    Cardiovascular Magnetic Resonance Imaging
    SPECT
    Single Photon Emission Computer Tomography
    NIHSS
    NIH-stroke scale
    mRS
    Modified Rankin Scale
    ECG
    Electrocardiography
    IQR
    Interquartile range
    VES
    Ventricular extrasystole
    SVES
    Supraventricular extrasystole
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted September 24, 2023.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Cardiac complications following cerebrovascular disease
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Cardiac complications following cerebrovascular disease
    Marco Heinrich Rohner, Catherine Gebhard, Andreas Luft, Martin Hänsel, Susanne Wegener
    medRxiv 2023.09.21.23295936; doi: https://doi.org/10.1101/2023.09.21.23295936
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Cardiac complications following cerebrovascular disease
    Marco Heinrich Rohner, Catherine Gebhard, Andreas Luft, Martin Hänsel, Susanne Wegener
    medRxiv 2023.09.21.23295936; doi: https://doi.org/10.1101/2023.09.21.23295936

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)